Why Nuvve Holding Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Nuvve Holding Corp. (NASDAQ:NVVE) fell sharply during Monday’s session after the company reported worse-than-expected fourth-quarter financial results.

Nuvve Holding posted a quarterly loss of $6.98 per share, versus market estimates for a loss of $5.60 per share. The company’s sales came in at $1.65 million, compared to expectations of $3.00 million.

Nuvve Holding shares dipped 29.6% to $0.7746 on Monday.

Here are some other stocks moving in today's mid-day session.

Gainers

• Vast Renewables Limited (NASDAQ:VSTE) shares jumped 179% to $8.62 after jumping 39% on Thursday.
• CXApp Inc. (NASDAQ:CXAI) gained 151% to $6.15 after the company announced a partnership with Google Cloud for acceleration of the CXAI platform.
• Sunshine Biopharma, Inc. (NASDAQ:SBFM) rose 94% to $0.1176 after the company FY23 operating results.
• MediaCo Holding Inc. (NASDAQ:MDIA) shares climbed 40.4% to $0.7312 after dipping more than 17% on Thursday.
• SPAR Group, Inc. (NASDAQ:SGRP) gained 37% to $1.33 after the company reported Q4 financial results and announced the sale of its interest in South Africa and Brazil for roughly $22 million.
• Meta Materials Inc. (NASDAQ:MMAT) gained 36.3% to $4.18. Meta Materials will host a corporate update webcast on Wednesday, April 3, 2024, at 4:30 PM EDT.
• Doma Holdings Inc. (NYSE:DOMA) shares climbed 34% to $6.08 after the company entered a merger transaction with TRG to go private at $6.29 per share in cash.
• IM Cannabis Corp. (NASDAQ:IMCC) gained 32% to $0.70. IMC applauded the April 1st implementation of the new Israeli cannabis regulation, facilitating access for many new patients.
• Xilio Therapeutics, Inc. (NASDAQ:XLO) gained 30% to $1.40. Xilio Therapeutics shares jumped 69% on Thursday after the company announced an exclusive license agreement with Gilead Sciences for a tumor-activated IL-12 program.
• Trio Petroleum Corp. (NYSE:TPET) rose 30% to $0.1099.
• Ondas Holdings Inc. (NASDAQ:ONDS) gained 28.8% to $1.25 after the company reported better-than-expected fourth-quarter revenue results.
• HeartCore Enterprises, Inc. (NASDAQ:HTCR) rose 22.6% to $1.19. HeartCore Enterprises announced that it has authorized a dividend payment in the amount of 2 cents per share of Common Stock.
• Mesoblast Limited (NASDAQ:MESO) rose 22.4% to $6.13 after the FDA earlier in the week informed the company that the available clinical data from its Phase 3 study MSB-GVHD001 appears sufficient to support submission of the proposed Biologics License Application for remestemcel-L.
• Emeren Group Ltd (NYSE:SOL) gained 22.3% to $2.36. The company reported fourth-quarter financial results.
• Lytus Technologies Holdings PTV. Ltd. (NASDAQ:LYT) gained 20.5% to $5.58.
• Ouster, Inc. (NYSE:OUST) gained 19.8% to $9.51.
• Global Gas Corporation (NASDAQ:HGAS) gained 18.6% to $1.66.
• Iris Energy Limited (NASDAQ:IREN) gained 16% to $6.26. Cantor Fitzgerald analyst Josh Siegler reiterated Iris Energy with an Overweight and maintained a $10 price target.
• GigaCloud Technology Inc. (NASDAQ:GCT) gained 13.3% to $30.26.
• DouYu International Holdings Limited (NASDAQ:DOYU) rose 12% to $7.38.
• Trip.com Group Limited (NASDAQ:TCOM) gained 7.6% to $47.24. Citigroup analyst Brian Gong maintained Trip.com Group with a Buy and raised the price target from $53 to $55.
• Micron Technology, Inc. (NASDAQ:MU) gained 6.6% to $125.69 after B of A Securities maintained a Buy rating on the stock and raised its price target from $120 to $144.
• Western Digital Corporation (NASDAQ:WDC) gained 5.7% to $72.13.

Losers

• Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) shares fell 72.8% to $1.36.
• Andretti Acquisition Corp. (NASDAQ:ZPTA) fell 53.6% to $6.96.
• Disc Medicine, Inc. (NASDAQ:IRON) shares dipped 51.8% to $30.00 after the company reported topline results from the Phase 2 AURORA study of bitopertin in patients with EPP.
• Logistic Properties Of The Americas (NYSE:LPA) fell 43.5% to $9.03.
• AEON Biopharma, Inc. (NYSE:AEON) fell 41.6% to $6.77 after the company reported a fourth-quarter loss of 71 cents per share.
• Sharecare, Inc. (NASDAQ:SHCR) fell 32.2% to $0.5208. announced financial results for the quarter and year ended Dec. 31, 2023. BTIG analyst David Larsen downgraded Sharecare from Buy to Neutral.
• Biora Therapeutics, Inc. (NASDAQ:BIOR) fell 32.2% to $0.7480. Biora Therapeutics announced a $6 million registered direct offering priced at-the-market under Nasdaq rules.
• ENDRA Life Sciences Inc. (NASDAQ:NDRA) fell 29.9% to $0.4075 after the company reported fourth-quarter results.
• Splash Beverage Group, Inc. (NYSE:SBEV) declined 28.3% to $0.33.
• Surrozen, Inc. (NASDAQ:SRZN) fell 27% to $11.00 after the company announced an approximately $192.5 million private placement of securities.
• Intellinetics, Inc. (NYSE:INLX) dipped 26.2% to $6.52 after the company reported worse-than-expected fourth-quarter GAAP EPS results.
• Orgenesis Inc. (NASDAQ:ORGS) fell 25.5% to $ 0.6126.
• GCT Semiconductor Holding, Inc. (NYSE:GCTS) declined 20.5% to $26.26. GCT Semiconductor appointed Nelson C. Chan to Board of Directors.
• Pulse Biosciences, Inc. (NASDAQ:PLSE) fell 16% to $7.32 after the company reported fourth-quarter financial results. Also, the company announced plans to initiate a rights offering of up to $60 million worth of units.
• Canopy Growth Corporation (NASDAQ:CGC) declined 12% to $7.60.
• AMC Entertainment Holdings, Inc. (NYSE:AMC) fell 12% to $3.2750.
• Borr Drilling Limited (NYSE:BORR) fell 11.7% to $6.05.
• Rumble Inc. (NASDAQ:RUM) fell 11.5% to $7.15.
• Walgreens Boots Alliance, Inc. (NASDAQ:WBA) fell 7.1% to $20.16. Truist Securities analyst David Macdonald maintained Walgreens with a Hold and maintained a $25 price target.

Now Read This: Paychex Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call